Real Innovation Awards 2017: The Alexander Fleming Serendipity winner

Physical chemist Jeff Weer invented the first and only dry-powder inhaled antibiotic for cystic fibrosis patients. His inspiration came from the most unexpected source: baseball.

by Andrew Saunders

Most people, faced with the same question, would simply assume that there is no meaningful connection between baseball and a brand new treatment for chronic respiratory diseases like cystic fibrosis and COPD, and move on. But happily physical chemist and keen amateur baseball pitcher Jeff Weers is not most people.

Working in medical research, Weers was only too aware of the problems with existing dry powder inhalers – chiefly that most of the powder used to deliver the drug gets stuck to the sides of the respiratory tract rather than making it to the lungs where it is needed. So he started to wonder about the nature of the powder particles themselves.

He knew from his baseball experience that a perforated, lightweight, hollow plastic kids’ ball not only travels much more slowly than a solid match ball, it can also be made to follow a much more curved trajectory.

Sign in to continue

Sign in

Trouble signing in?

Reset password: Click here


Call: 020 8267 8121



  • Up to 4 free articles a month
  • Free email bulletins

Register Now

Become a subscriber

From £66 a quarter

  • Full access to
  • Exclusive event discounts
  • Management Today's print magazine
  • Plus lots more, including our State of the Industry Report.

Choose a Package